TopNewsToday.org
»
»
»

Bayer says drug shows promise vs. gastrointestinal cancer

yahoo.com (1 year and 10 months ago)

Jun 4, 2012

FRANKFURT (Reuters) - German drugmaker Bayer said trials showed its potential blockbuster regorafenib prolonged the lives of patients with an aggressive type of gastrointestinal cancer without their tumors worsening, and it will seek approval for wider use of the drug. The 199-patient late-stage trial showed the drug prolonged the lives of patients with metastatic gastrointestinal stromal tumors, or GIST, by almost four months on average... full story

More news more news

Bayer says drug shows promise vs. gastrointestinal cancer

reuters.com (1 year and 10 months ago)

ASCO 2012 Live Blog -- Monday

thestreet.com (1 year and 10 months ago)

Boehringer plans to challenge lung cancer drugs

yahoo.com (1 year and 10 months ago)

Brendan T. Hoffman’s New Book Began with a Promise

yahoo.com (1 year and 10 months ago)

Cancer drug Avastin slows ovarian cancer progression, study shows

foxnews.com (1 year and 10 months ago)

Boehringer plans to challenge lung cancer drugs

reuters.com (1 year and 10 months ago)

Experimental Roche breast cancer drug slows tumor growth, study shows

foxnews.com (1 year and 10 months ago)

New 'Personalized' Drugs Show Promise Against Melanoma, Lung Cancer

yahoo.com (1 year and 10 months ago)

Casa Vinicola Zonin USA Supports Breast Cancer Awareness Month by Donating $1.00 per Bottle Sold of Zonin Sparkling Rose

yahoo.com (1 year and 10 months ago)

New Cancer Data Shine Spotlight On The Secret Committees That Make Medicine's Toughest Decisions

forbes.com (1 year and 10 months ago)

More Latin America news »

US | Sport | Business | Technology | Lifestyle | Entertainment | World | Search
Privacy Policy | About | Contacts
All news and photos belong to their authors.